Dokument: Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years

Titel:Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=75134
URN (NBN):urn:nbn:de:hbz:061-20261117-144754-1
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Wargenau, Manfred [Autor]
Mutzke, Eva [Autor]
Klingmann, Viviane [Autor]
Spitzhorn, Lucas-Sebastian [Autor]
Reidemeister, Sibylle [Autor]
Klingmann, Ingrid [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]508,6 KB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 18.11.2026 / geändert 18.11.2026
Stichwörter:mini-tablets; pediatric formulation; medicine dosage form; medicinal product administration
Beschreibung:Background/Aims: This preference study aimed to identify the maximum number of mini-tablets of two different sizes that children and adolescents would be willing to take, and parents, nurses, and pediatricians would be willing to administer to children and adolescents.
Methods: A total of 336 participants (24 per cohort) were stratified into 14 cohorts: Acutely and chronically sick children/adolescents aged 6–<12 years (y) and 12–<18 y, parents of acutely and chronically sick children/adolescents aged 0–<2 y, 2–<6 y, 6–<12 y, and 12–<18 y, nurses, and pediatricians. After participants were shown seven different numbers of 2 and 3 mm mini-tablets, they were asked to assess the maximum number acceptable for short-, middle-, and long-term treatment using cohort-specific questionnaires.
Results: Within all groups and treatment durations, the specified maximum accepted number of 2 mm mini-tablets was higher than the number of 3 mm mini-tablets. The maximum number of mini-tablets acceptable to the participants increased with increasing age of the children and ranged from 40–500 (30–400) for the 2 mm (3 mm) mini-tablets. With increasing duration of treatment, a lower maximum number of mini-tablets was considered
tolerable. Chronically sick children were willing to take higher numbers of mini-tablets than acutely sick children. The maximum accepted numbers of mini-tablets specified by pediatric patients, parents, and healthcare professionals were similar for each age group; however, pediatricians consistently specified slightly higher numbers of mini-tablets than
parents and nurses.
Conclusions: The study demonstrated that even a high number of mini-tablets would be well-accepted by children during middle- or long-term treatment.
Rechtliche Vermerke:Originalveröffentlichung: Wargenau, M., Mutzke, E., Spitzhorn, L.-S., Reidemeister, S., Klingmann, I., & Klingmann, V. (2025). Survey Study to Identify the Maximum Acceptable Numbers of 2 mm and 3 mm Mini-Tablets for Short-, Middle-, and Long-Term Treatments in Acutely and Chronically Sick Children of Different Age Groups Below 18 Years. Pharmaceutics, 17(7), Artikel 834. https://doi.org/10.3390/pharmaceutics17070834
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:17.11.2026
Dateien geändert am:18.11.2026
english
Benutzer
Status: Gast
Aktionen